The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The relationship between response and dose in published, contemporary phase 1 oncology trials.
 
Antonious Ziad Hazim
No Relationships to Disclose
 
Emerson Yu-sheng Chen
Other Relationship - Horizon CME; Taiho Pharmaceutical
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; ImmunoMET; SignalChem; Spindletop Ventures; Tarveda Therapeutics
Honoraria - AstraZeneca; Celgene; ImmunoMET; Nuevolution; PDX Pharmacy; Symphogen; Tarveda Therapeutics; Tesaro
Consulting or Advisory Role - AstraZeneca; Critical Outcome Technologies; ImmunoMET; PDX Pharmacy; SignalChem; Symphogen; Takeda/Millennium; Tarveda Therapeutics
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; ImmunoMET; Ions Pharmaceuticals; Karus Therapeutics; NanoString Technologies; Ovarian Cancer Research Foundation; Pfizer; Prospect Creek Foundation; Tarveda Therapeutics
Patents, Royalties, Other Intellectual Property - DSP technology patent with Nanostring; HRD assay to Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca; Chrysalis Biomedical Advisors; ImmunoMET; Michigan Primary Care Consortium; Pfizer; Symphogen
 
Vinay Prasad
Patents, Royalties, Other Intellectual Property - I am a paid writer for Medscape; I make a podcast called Plenary Session and we have backers on Patreon, these are individuals who contribute for us to make the podcast; I receive Royalties from my book Ending Medical Reversal; I received an advance for a book entitled: Malignant Johns Hopkins Press